Cardiotoxicity of Euodia rutaecarpa(Juss.) Benth. Based on Network Pharmacology and Untargeted Metabolomics

doi:10.19803/j.1672-8629.20240472

Abstract

Abstract: Objective To explore the potential mechanisms of cardiotoxicity of Euodia rutaecarpa, a long-used traditional Chinese medicine, in order to contribute to clinical safety and risk prevention. Methods Network pharmacology was employed to analyze the target pathways of Euodia rutaecarpa that acted on the heart. In combination with untargeted metabolomics, the impact of Euodia rutaecarpa on cardiac metabolic pathways was investigated in order to find out about the potential mechanisms of cardiotoxicity. Results Network pharmacology identified 51 intersecting targets between Euodia rutaecarpa and cardiotoxicity, such as TNF, IL-6, IL-1β, TP53, and CASP3. These targets were involved in key signaling pathways such as the Advanced Glycation End Products-Receptor (AGE-RAGE) and Mitogen-Activated Protein Kinase (MAPK) pathways. Metabolomics analysis revealed metabolic pathways, including purine metabolism, biosynthesis of valine, leucine, and isoleucine, and the citric acid (TCA) cycle. The combination of network pharmacology and untargeted metabolomics suggested that the cardiotoxicity of Euodia rutaecarpa was related to myocardial energy metabolism, potentially via the disruption of the intracellular TCA cycle, purine metabolism, and protein synthesis and degradation. Conclusion The cardiotoxicity of Euodia rutaecarpa is closely related to its impact on myocardial energy metabolism and exhibits bidirectional effects on the heart. Clinicians should be cautious regarding dosage and symptoms while attaching importance to drug monitoring.

Key words: Euodia Rutaecarpa (Juss.) Benth., Cardiotoxicity, Pharmacovigilance, Network Pharmacology, Untargeted Metabolomics

CLC Number:

R96
RR994.11

YIN Xiaoyang, ZHANG Xiaomeng, LIU Zeyu, LIU Yadi, WANG Yu, LIN Zhijian, ZHANG Bing. Cardiotoxicity of Euodia rutaecarpa(Juss.) Benth. Based on Network Pharmacology and Untargeted Metabolomics[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1216-1223.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/10.19803/j.1672-8629.20240472

https://zgywjj.magtechjournal.com/EN/Y2024/V21/I11/1216

References

[1] WEI YM, LIANG Y.Discussion on Wu Zhu Yu as the Primary Medicine for Jueyin Disease with Pure Yin Syndrome[J/OL]. Journal of Practical Traditional Chinese Internal Medicine, 1-7[2024-07-08].https://www.cnki.com.cn/Article/CJFDTotal-SYZY20240527004.htm.
[2] ZHAO JB, LI YC, ZHANG Z, et al.Toxicity Verification and Dual Use as Medicine and Food of Wu Zhu Yu in Dunhuang Manuscripts[J]. Asia-Pacific Traditional Medicine(亚太传统医药), 2023, 19(9): 197-200
[3] DESTERE A, MERINO D, LAVRUT T, et al.Drug-Induced Cardiac Toxicity and Adverse Drug Reactions, a Narrative Review[J]. Therapie, 2024, 79(2): 161-172.
[4] WEI ST.Exploration of the“Dose-Time-Toxicity”Relationship and Material basis of Wuzhuyu-induced Liver Injury[D]. Shanghai: China Academy of Chinese Medical Sciences(中国医药工业研究总院), 2022.
[5] FANG YQ, WANG GT, YANG C.Rational Application of Evodia Rutaecarpa[J]. Northwest Pharmaceutical Journal(西北药学杂志), 2003(5): 239-240.
[6] YANG CQ, LIAN WY, WANG YG, et al.Research Progress on Pharmacology and Toxicology of Evodiamine[J]. Chinese Journal of Traditional Chinese Medicine(中国中药杂志), 2021, 46(20): 5218-5225.
[7] LYU SX, JIAO HC.Research Progress on Cardiotoxicity Mechanisms of Common Traditional Chinese Medicines[J]. Chinese Medicine Information(中医药信息), 2024, 41(6): 82-88.
[8] DENG YH, CHEN L, PENG M, et al.In Vivo and in Vitro Experimental Study on Cardiac Toxicity of Evodiamine Alkaloids[J]. Chinese Pharmacist(中国药师), 2021, 24(4): 653-657.
[9] YANG W, MA L, LI S, et al.Evaluation of the Cardiotoxicity of Evodiamine in vitro and in vivo[J]. Molecules (Basel, Switzerland), 2017, 22(6), 943.
[10] ZHANG D, LYU J, REN Z, et al.Potential Cardiotoxicity Induced by Euodiae Fructus: In Vivo and In Vitro Experiments and Untargeted Metabolomics Research[J]. Frontiers in Pharmacology, 2022, 13: 1028046.
[11] HUANG YX, HE XY, ZENG XJ, et al.The Significance of NOD-like Receptor Protein 3 Inflammasome in Doxorubicin-Induced Cardiac Toxicity[J]. Anhui Medicine(安徽医药), 2024, 28(5): 860-864.
[12] TAO H, SHEN X, ZHANG C, et al.Research Progress on New-Onset Atrial Fibrillation after Cardiac Surgery[J]. Progress in Cardiovascular Diseases(心血管病学进展), 2024, 45(3): 234-237.
[13] SUN SN.Progress in Etiology and Pathogenesis of Pediatric Myocarditis[J]. Chinese Journal of Practical Pediatrics(中国实用儿科杂志), 2024, 39(3): 183-192.
[14] QUAN WX, MIAO YD, MI DH.Pharmacological Mechanism and Efficacy Substance Study of Qiliqiangxin Capsule in Treating Dilated Cardiomyopathy Based on Network Pharmacology of Compound Chinese Medicine and Molecular Docking Technology[C]. The 20th International Congress on Luobing Theory(第二十届国际络病学大会论文集), 2024.
[15] YU CZ, LAI Y, FU Q, et al.Exploring the Mechanism of Xinkang Granules in Treating Chronic Heart Failure Based on Network Pharmacology[J]. Journal of Integrative Medicine on Cardio-Cerebrovascular Disease(中西医结合心脑血管病杂志), 2023, 21(7): 1169-1180.
[16] DING BJ.Elucidation of the Active Ingredients and Multilevel Mechanisms of Jixuecao in Anti-Cardiac Hypertrophy Based on Systematic Pharmacology[D]. Xi’an: Northwest University, 2023.
[17] WANG XQ.The Influence of Angelica Red Astragalus Ultrafiltrate on the Inflammatory Status of Heart Failure Rats[D]. Lanzhou: Gansu University of Chinese Medicine(甘肃中医药大学), 2023.
[18] YI XJ.Study on the mechanism of Danhong Injection in Resisting Aconitine-Induced Cardiotoxicity Based on Systems Biology[D]. Hangzhou: Zhejiang University(浙江大学), 2019.
[19] SHAO W, GU J, HUANG C, et al.Malignancy-Associated Metabolic Profiling of Human Glioma Cell Lines Using 1H NMR Spectroscopy[J]. Mol Cancer, 2014, 13:197.
[20] LI A, GUO X, XIE J, et al.Validation of Biomarkers in Cardiotoxicity Induced by Periplocin on Neonatal Rat Cardiomyocytes Using UPLC-Q-TOF/MS Combined with a Support Vector Machine[J]. J Pharm Biomed Anal, 2016, 123: 179-185.
[21] ZHANG SH, LI JQ.Research Progress on the Mechanism of Cardiotoxic Effects of Aconitine[J]. Journal of Integrated Traditional Chinese and Western Medicine in Cardiovascular and Cerebrovascular Diseases(中西医结合心脑血管病杂志), 2018, 16(10): 1366-1370.
[22] WU J, YU XY, XU Y, et al.Metabolomics Study on the Cardiotoxicity of Doxorubicin Induced Lung Injury in Mice[J]. Journal of China Pharmaceutical University, 2023,54(2): 198-207.
[23] WANG BQ, GU N.Research Progress and Prospects of Traditional Chinese Medicine Intervention in Ventricular Remodeling after Acute Myocardial Infarction[J]. Chinese Journal of Traditional Chinese Medicine(中华中医药学刊), 2022, 40(8): 103-107.
[24] XU YK, YANG PL, LIU Y, et al.Advances in Research on Cardiac Mitochondrial Dynamics and Biogenesis in Heart Failure[J]. Chinese Journal of Integrative Medicine on Cardio-cerebrovascular Disease(中西医结合心脑血管病杂志), 2024, 22(6): 1046-1050.
[25] LIU R, YI X, WU XL, et al.Effects of Ge Hua Jie Jiu Di Zhi Tang on Hepatic Tissue Energy Metabolism in Mice with Alcoholic Liver Disease[J]. Journal of Beijing University of Chinese Medicine(北京中医药大学学报), 2024, 47(5): 662-671.
[26] SOLINSKY R, PARK K, BETANCOURT l, et al. Patient Perceptions and Clinical Assessments of Cardiometabolic Disease After Subacute Spinal Cord Injury[J]. Archives of Physical Medicine and Rehabilitation, 2024, 105(5): 901-905.
[27] WANG XF, ZHANG XM, ZHANG B, et al.Thoughts on Pediatric Ancient Literature-based Pharmacovigilance and Pharmaceutical Services in Traditional Chinese Medicine[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2022, 19(6): 591-594, 609.